IDEX (IEX)
(Delayed Data from NYSE)
$220.42 USD
-0.21 (-0.10%)
Updated May 3, 2024 04:00 PM ET
After-Market: $220.44 +0.02 (0.01%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth C Momentum C VGM
Price, Consensus and EPS Surprise
IEX 220.42 -0.21(-0.10%)
Will IEX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for IEX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for IEX
Ingersoll Rand (IR) Q1 Earnings Top Estimates, Revenues Miss
Tetra Tech (TTEK) Beats on Q2 Earnings, Raises 2024 Guidance
IEX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Stanley Black's (SWK) Q1 Earnings Beat, Revenues Down Y/Y
Howmet (HWM) Q1 Earnings Beat Estimates, Revenues Increase Y/Y
Illinois Tool (ITW) Q1 Earnings Beat Estimates, Revenues Miss
Other News for IEX
Peering Into IDEX's Recent Short Interest
IDEX Q1 Performance Review: Solid Earnings with Short-Term Challenges – Hold Rating Justified
Decoding IDEX Corp (IEX): A Strategic SWOT Insight
Analysts Offer Insights on Industrial Goods Companies: IDEX (IEX), Boeing (BA) and Universal Technical Institute (UTI)
RBC Capital Remains a Buy on IDEX (IEX)